Keyword: biopharmaceuticals
Plant Construction & Process Technology
09.05.2014
- New legislation, expiring patents and increasing healthcare costs call for decisive changes in the global pharmaceutical industry. New markets for specialty medicines...
News
07.04.2014
- Merck Serono, the Swiss-based biopharmaceutical division of Germany's Merck KGaA, has signed an exclusive license agreement with U.S. reproductive medicine specialist Auxogyn of...
News
18.03.2014
- Merck Serono, the biopharmaceutical division of Germany's Merck KGaA, has named Meeta Gulyani as head of strategy and global franchises, effective May 7. She will be based in...
News
23.12.2013
- Merck Serono, the biopharmaceuticals division of Germany's Merck KGaA, has signed a global license agreement with the Spanish National Research Center (CNIO) in Madrid on cancer...
News
28.11.2013
- German chemicals and pharmaceuticals producer Merck KGaA plans to invest €80 million in a new pharmaceutical plant in the Nantong Economical Technological Development Area of...
Plant Construction & Process Technology
12.11.2013
- Development On Trial - The number of biopharmaceutical projects in clinical trials and products is increasing, playing an important role in new treatments. Many of these projects...
News
28.10.2013
- Merck Serono, the biopharmaceuticals arm of Germany's Merck KGaA, has agreed an oncology research pact with Polish biotech company Selvita. The aim of the collaboration is to...
News
22.10.2013
- Europe's medicines regulator has come out fighting for greater transparency for clinical trials, arguing that its controversial policy to end data secrecy will be "a boon to drug...
